Back to Search
Start Over
Immune Thrombocytopenic Purpura in Patients with COVID-19.
- Source :
-
European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2020 Jun 09; Vol. 7 (7), pp. 001751. Date of Electronic Publication: 2020 Jun 09 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.<br />Learning Points: The severity of haemorrhagic syndrome is not correlated with the severity of COVID-19 infection.Thrombocytopenia in mild COVID-19 infection seems to have an autoimmune mechanism.Intravenous immunoglobulins (1 g/kg) should be the first line of treatment.<br />Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interests.<br /> (© EFIM 2020.)
Details
- Language :
- English
- ISSN :
- 2284-2594
- Volume :
- 7
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- European journal of case reports in internal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 32665935
- Full Text :
- https://doi.org/10.12890/2020_001751